NIH asked to extend comments on proposed license to Atara Biotherapeutics for patents on Anti-Mesothelin Chimeric Antigen Receptor (CAR) for the Treatment of Human Cancer

On July 9, 2018, KEI asked the NIH to extend the deadline for comments described on the Federal Register notice 83 FR 30448 until information about the enrollment and costs of NIH-funded clinical trials involving mesothelin expressing cancers, and trials… Continue Reading

Litigation: KEI v. NIH et al.

On April 19, 2018, KEI filed a lawsuit against the NIH license of CD30 CAR T patents to Gilead. This page provides current information on this ongoing litigation. KEI blogs 2018: Briefing note on NIH proposed license to Gilead for CD-30 CAR… Continue Reading

KEI comments on prospective exclusive NIH license to streptococcus pneumonia patents, for the University of Liverpool

On July 2, 2018, Knowledge Ecology International (KEI) filed comments to the National Institutes of Health (NIH) regarding the prospective grant of an exclusive license to the University of Liverpool, located in the U.K. The inventions described in the Federal… Continue Reading